Pooled performance of the POC antigen detection and near-patient NAATs for different specimen types
| Specimen type | Antigen detection point-of-care tests | Near-patient NAATs | ||||
| Number of studies; N | Sensitivity (95% CI) | Specificity (95% CI) | Number of studies; N | Sensitivity % (95% CI) | Specificity % (95% CI) | |
| Cervical swab | 8; 4588 | 53.1% (34.7 to 70.8) | 98.9% (98.0 to 99.4) | 1; 1713 | 97.4% | 99.6% |
| Vaginal swab | 10; 6252 | 36.6% (22.9 to 52.9) | 96.9% (94.0 to 98.4) | 1; 1710 | 98.7% | 99.4% |
| Male urine | 5; 2568 | 62.5% (43.2 to 78.5) | 98.0% (95.1 to 99.0) | 1; 1386 | 97.5% | 99.9% |
| Female urine | – | – | – | 1; 1718 | 97.6% | 99.8% |
| Male rectal swab | – | – | – | 1; 409 | 86% | 99.2% |
NAAT, nucleic acid amplified test; POC, point of care.